Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 08, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage...